Atlas Trials

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Clinical trial NCT03893825 · COMPLETED

Trial details

NCT number
NCT03893825
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2019-04-17
Primary completion
2021-12-02
Enrollment
336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.